145 related articles for article (PubMed ID: 11035699)
1. Methemoglobinemia after infusion of ifosfamide chemotherapy: first report of a potentially serious adverse reaction related to ifosfamide.
Hadjiliadis D; Govert JA
Chest; 2000 Oct; 118(4):1208-10. PubMed ID: 11035699
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide-induced encephalopathy in patients with uterine sarcoma.
Liu YL; Tsai SH; Chang FW; Yu MH
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):77-80. PubMed ID: 20466298
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide with and without adriamycin in advanced uterine leiomyosarcoma.
Hawkins RE; Wiltshaw E; Mansi JL
Cancer Chemother Pharmacol; 1990; 26 Suppl():S26-9. PubMed ID: 2347045
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic uterine leiomyosarcoma with cisplatin, pirarubicin, and ifosfamide.
Hirota Y; Miyamura K; Hayata T; Miyakawa I
Gynecol Obstet Invest; 1997; 44(1):70-2. PubMed ID: 9251960
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.
Sutton G; Blessing JA; Malfetano JH
Gynecol Oncol; 1996 Aug; 62(2):226-9. PubMed ID: 8751554
[TBL] [Abstract][Full Text] [Related]
7. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
[TBL] [Abstract][Full Text] [Related]
8. [Sequential course and prospective management of ifosfamide-induced multi-organ toxicity].
Mollenkopf A; du Bois A; Meerpohl HG
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):525-8. PubMed ID: 9036065
[TBL] [Abstract][Full Text] [Related]
9. Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.
Minobe S; Todo Y; Suzuki Y; Aoyagi Y; Umazume T; Okamoto K; Kato H
J Obstet Gynaecol Res; 2011 Jun; 37(6):645-9. PubMed ID: 21375676
[TBL] [Abstract][Full Text] [Related]
10. High-dose tamoxifen modulates drug resistance to doxorubicin, dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma.
Yeh KH; Lu YS; Hsiao CH; Cheng AL
Anticancer Res; 2003; 23(6D):5133-7. PubMed ID: 14986591
[TBL] [Abstract][Full Text] [Related]
11. A Rare Case of Methemoglobinemia after Ifosfamide Infusion in a 3-Year-Old Patient Treated for T-ALL.
Suprunowicz M; Marcinkiewicz K; Leszczyńska E; Krętowska-Grunwald A; Płonowski M; Tałałaj M; Dakowicz Ł; Krawczuk-Rybak M; Sawicka-Żukowska M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612599
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
Brunello A; Basso U; Rossi E; Stefani M; Ghiotto C; Marino D; Crivellari G; Monfardini S
Drugs Aging; 2007; 24(11):967-73. PubMed ID: 17953463
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel by 72-hour continuous infusion followed by bolus intravenous ifosfamide or epirubicin: results of two phase I studies.
Miglietta L; Marenghi C; Nizzo R; Foglia G; Ragni N; Boccardo F
Oncology; 2001; 60(2):116-22. PubMed ID: 11244325
[TBL] [Abstract][Full Text] [Related]
14. Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centers.
Sanfilippo R; Grosso F; Jones RL; Banerjee S; Pilotti S; D'Incalci M; Dei Tos AP; Raspagliesi F; Judson I; Casali PG
Gynecol Oncol; 2011 Dec; 123(3):553-6. PubMed ID: 21917307
[TBL] [Abstract][Full Text] [Related]
15. Two episodes of ifosfamide-related neurotoxicity in the same patient following different schedules and doses of the drug. A case report.
Comandone A; Liboni W; Picci P; Oliva C; Pignatta P; Dal Canton O; Bergnolo P; Cutin SC; Boglione A
Tumori; 2000; 86(6):483-6. PubMed ID: 11218192
[TBL] [Abstract][Full Text] [Related]
16. The influence of lidocaine topical anesthesia during transesophageal echocardiography on blood methemoglobin level and risk of methemoglobinemia.
Filipiak-Strzecka D; Kasprzak JD; Wiszniewska M; Walusiak-Skorupa J; Lipiec P
Int J Cardiovasc Imaging; 2015 Apr; 31(4):727-31. PubMed ID: 25663608
[TBL] [Abstract][Full Text] [Related]
17. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
[TBL] [Abstract][Full Text] [Related]
18. METHEMOGLOBINEMIA--AN ALTERNATIVE TREATMENT MODALITY.
Saleem MK; Kashif M; Javed MW; Raza A; Siddiqui AM
J Ayub Med Coll Abbottabad; 2015; 27(2):492-3. PubMed ID: 26411149
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Reactivation After Ifosfamide Therapy for Retroperitoneal Sarcoma.
Chhibar P; Zhu Z; Cheedella NK; Chaudhry R; Wang JC
Am J Case Rep; 2016 Jun; 17():371-4. PubMed ID: 27246626
[TBL] [Abstract][Full Text] [Related]
20. Nonconvulsive status epilepticus due to ifosfamide.
Kilickap S; Cakar M; Onal IK; Tufan A; Akoglu H; Aksoy S; Erman M; Tekuzman G
Ann Pharmacother; 2006 Feb; 40(2):332-5. PubMed ID: 16449538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]